Isis falls after mipomersen update

Isis Pharmaceuticals Inc. (NASDAQ:ISIS) fell $2.28 (17%) to $11.12 on Tuesday after it and partner

Read the full 153 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE